Skip to content

Atazanavir in treatment-experienced people: boosted looks better

Atazanavir approval recommended in US

Recent HSV infection substantially increases chances of HIV infection

Expert panel maps global 'HIV prevention gap': $6 billion needed by 2007

SA government gets chance to rethink AIDS treatment policy

T-cell activation means lower CD4 gains in HAART treated HIV patients

Switch from d4T to abacavir gives `modest` fat gains

HIV doctors should be actively involved in prevention initiatives - but is this realistic?

MSF highlights need for cheaper paediatric drugs in global ARV price survey